Loading...
XNAS
VERO
Market cap3mUSD
Jun 10, Last price  
2.52USD
1D
-10.00%
1Q
-12.20%
IPO
-99.88%
Name

Restoration Robotics Inc

Chart & Performance

D1W1MN
P/E
143.58
P/S
0.06
EPS
0.02
Div Yield, %
Shrs. gr., 5y
47.63%
Rev. gr., 5y
-10.10%
Revenues
65m
-15.09%
17,230,00015,600,00021,297,00021,956,000110,406,00078,014,000105,622,00099,497,00076,354,00064,833,000
Net income
25k
P
-22,971,000-21,846,000-17,842,000-28,726,000-42,295,000-82,818,000-22,141,000-43,584,000-37,250,00025,000
CFO
-11m
L-13.94%
-24,118,000-16,164,000-19,256,000-28,699,000-39,595,000-28,650,000-19,771,000-26,980,000-12,859,000-11,066,000
Earnings
Aug 11, 2025

Profile

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss, a device for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; and ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles. The company is headquartered in Toronto, Canada.
IPO date
Oct 12, 2017
Employees
384
Domiciled in
CA
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
64,833
-15.09%
76,354
-23.26%
99,497
-5.80%
Cost of revenue
92,017
104,663
134,373
Unusual Expense (Income)
NOPBT
(27,184)
(28,309)
(34,876)
NOPBT Margin
Operating Taxes
(47,607)
(71)
(722)
Tax Rate
NOPAT
20,423
(28,238)
(34,154)
Net income
25
-100.07%
(37,250)
-14.53%
(43,584)
96.85%
Dividends
Dividend yield
Proceeds from repurchase of equity
987
7,077
8,653
BB yield
Debt
Debt current
1,322
5,745
9,542
Long-term debt
36,753
77,114
80,252
Deferred revenue
671
957
Other long-term liabilities
1,306
1,864
Net debt
33,804
66,145
58,181
Cash flow
Cash from operating activities
(11,066)
(12,859)
(26,980)
CAPEX
(123)
(116)
(336)
Cash from investing activities
(123)
(116)
(336)
Cash from financing activities
10,064
6,802
8,009
FCF
40,320
(27,542)
(33,474)
Balance
Cash
4,271
5,396
11,569
Long term investments
11,318
20,044
Excess cash
1,029
12,896
26,638
Stockholders' equity
(308,400)
(261,303)
(223,431)
Invested Capital
347,619
329,528
318,639
ROIC
6.03%
ROCE
EV
Common stock shares outstanding
3,982
5,442
4,397
Price
Market cap
EV
EBITDA
(23,295)
(24,194)
(30,413)
EV/EBITDA
Interest
6,885
6,893
4,561
Interest/NOPBT